Referral and Goals
Referral source: [Self-referred, primary care, oncology or other. Name of referring clinician if any]
Indication: [Elective (age-related or social) or medical (planned chemotherapy, radiation, gonadal surgery, gender-affirming care, condition linked to early ovarian insufficiency)]
Age today: [Years]
Reproductive goals: [Children hoped for, intended timing of future pregnancy, partner status, openness to donor sperm or donor eggs later]
What the patient hopes to achieve: [In her own words, including number of cycles she is willing to consider]
Oncofertility Urgency
[Omit this section if not a medical referral]
Diagnosis and stage: [ ]
Planned treatment and start date: [Agent or modality, gonadotoxic risk as described by the oncology team, start date]
Time available for stimulation: [Days or weeks]
Hormone-sensitive disease: [Yes / No. If yes, note whether the oncology team agreed to a modified protocol]
Alternatives discussed: [Embryo freezing, ovarian tissue freezing, ovarian suppression, ovarian transposition, no preservation]
Oncology team contact: [Name and agreement to timeline]
History
Menstrual history: [Cycle length and regularity, last menstrual period, current hormonal contraception]
Gynecologic and obstetric history: [Pregnancies, endometriosis, ovarian cysts or surgery, polycystic ovary features]
Medical history: [Conditions that affect anesthesia, clotting or stimulation safety]
Medications and allergies: [ ]
Family history: [Early menopause, genetic conditions, hereditary cancer syndromes]
Lifestyle: [Smoking, alcohol, BMI. Omit if not discussed]
Ovarian Reserve and Workup
| Test | Date (cycle day) | Result |
|---|
| AMH | [ ] | [ ] |
| Antral follicle count (total, right / left) | [ ] | [ ] |
| FSH and estradiol | [ ] | [ ] |
| Pelvic ultrasound | [ ] | [Uterine and ovarian findings, ovarian access for retrieval] |
| Infectious disease screening | [ ] | [ ] |
| Other (TSH, prolactin, pregnancy test, carrier screening) | [ ] | [ ] |
Expectations Discussed
Expected response: [Anticipated oocyte yield range per cycle based on age, AMH and AFC, as estimated by the clinician]
Likelihood of a future live birth: [How the clinician framed chances given age at retrieval and expected egg numbers; that frozen eggs do not guarantee a pregnancy]
Number of cycles: [Whether more than one cycle may be needed to reach the patient’s goal]
Survival and use of frozen eggs: [Thaw survival, fertilization by ICSI, embryo development, transfer]
Age at future use: [Pregnancy risks at older maternal age, clinic limits on age at transfer]
Proposed Stimulation Plan
Protocol type: [Antagonist, agonist, random-start, letrozole-modified or other, as chosen by the clinician]
Start timing: [Cycle day start or random start; target start date]
Medications planned: [Medication names only; doses per the clinic protocol sheet]
Monitoring: [Ultrasound and bloodwork schedule]
Trigger approach: [Type of trigger planned]
Retrieval: [Anesthesia or sedation plan, location, escort required]
OHSS risk: [Low / moderate / high, with risk-reduction plan]
Cost, Storage and Consent
Cost discussed: [Cycle fees, medications, storage fees, future thaw and transfer costs, coverage or funding available]
Storage: [Facility, annual storage fee, review interval, transfer between clinics]
Disposition wishes: [What should happen to stored eggs in case of death, incapacity, or non-payment, or when no longer wanted: discard, donate to research, donate to others where permitted]
Consents: [Treatment consent, cryopreservation and storage agreement signed or provided to take home]
Assessment and Plan
Assessment: [Age, indication, ovarian reserve summary, suitability for stimulation]
Plan: [Next steps, outstanding tests, medication teaching visit, start date]
Follow-up: [When and how she will be contacted]